MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2023 International Congress

    Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study

    S. Joza, M. Hu, KY. Jung, D. Kunz, D. Arnaldi, JY. Lee, L. Ferini-Strambi, E. Antelmi, F. Sixel-Döring, V. de Cock, J. Montplaisir, M. Lawton, HJ. Kim, F. Bes, P. Mattioli, K. Woo, S. Marelli, G. Plazzi, B. Mollenhauer, A. Pelletier, JS. Sunwoo, N. Girtler, C. Trenkwalder, JF. Gagnon, R. Postuma (Montreal, Canada)

    Objective: To assess the progression and predictive value of neuropsychological testing on the development of dementia in idiopathic REM sleep behavior disorder (iRBD). Background: iRBD…
  • 2023 International Congress

    Technological visuo-cognitive training in Parkinson’s disease: Preliminary findings from a pilot randomised controlled trial

    J. Das, G. Barry, R. Vitorio, R. Walker, C. Mcdonald, R. Morris, S. Stuart (Newcastle upom Tyne, United Kingdom)

    Objective: To determine the feasibility and preliminary efficacy of a home-based, technological visuo-cognitive training (TVT) intervention using a mobile application and exercise with stroboscopic glasses…
  • 2023 International Congress

    Predictors of cognitive deficits in patients with idiopathic normal pressure hydrocephalus – a pilot MRI volumetric study

    I. Straka, V. Bolekova, K. Cho, M. Jezberova, P. Brandoburova, P. Valkovic, Z. Kosutzka (Bratislava, Slovakia)

    Objective: The pilot study aimed to identify neuroanatomical predictors of cognitive performance in patients with iNPH. Background: Idiopathic normal pressure hydrocephalus (iNPH) is a specific…
  • 2023 International Congress

    The East London Parkinson Disease Project – preliminary results from a diverse population

    A. Zirra, KC. Dey, E. Camboe, T. Haque, A. Ben-Joseph, J. Kahan, D. Gallagher, C. Budu, B. Huxford, C. Simonet, A. Lees, CR. Marshall, AJ. Noyce (London, United Kingdom)

    Objective: The East London Parkinson Disease (ELPD) project is a platform study to understand the manifestations and determinants of PD in a diverse population. Background:…
  • 2023 International Congress

    Effect of Sex on the association between GBA mutations and Cognitive Decline in Parkinson’s Disease

    SP. Caminiti, M. Avenali, M. Inglese, C. Tassorelli, D. Perani (Pavia, Italy)

    Objective: To assess the impact of sex and glucocerebrosidase (GBA) mutations on cognitive trajectories in a sample of Parkinson's disease (PD) patients. Background: Accumulating evidence…
  • 2023 International Congress

    3D Multi-Delay pCASL to Understand Perfusion Changes in Patients with Parkinson’s disease with Mild Cognitive Impairment

    B. Thomas, Z. Mari, V. Mishra (Dallas, USA)

    Objective: To understand perfusion changes in patients with Parkinson’s disease (PD) with well-characterized mild cognitive impairment (MCI) using 3D multi-delay pseudo-continuous Arterial Spin Labeling (pCASL)…
  • 2023 International Congress

    Does sex affect worsening of cognitive and IADL functions in PD with and without PD-MCI?

    I. Liepelt-Scarfone, M. Bode, S. Solbrig, K. Brockmann, W. Maetzler, I. Wurster, M. Timmers, D. Berg, S. Becker (Tübingen, Germany)

    Objective: To define how sex affects worsening of cognition and instrumental activities of daily living (IADLs) in a heterogeneous cohort of people with Parkinson’s disease…
  • 2023 International Congress

    Automatic cluster analysis using semantic relatedness for verbal fluency tasks in Parkinson’s disease

    T. Hähnel, T. Feige, J. Kunze, A. Epler, A. Frank, J. Bendig, N. Schnalke, M. Wolz, P. Themann, B. Falkenburger (Dresden, Germany)

    Objective: The aim of this work was to develop and validate a method for automated identification of semantically related clusters for verbal fluency tasks (VFT)…
  • 2023 International Congress

    Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson’s disease.The AMBITIOUS Study Protocol

    F. Colucci, M. Avenali, R. de Micco, A. Bacila, S. Cerri, G. Cuconato, V. Franco, D. Franciotta, C. Ghezzi, M. Gastaldi, C. Galandra, G. Germani, P. Mitrotti, G. Ongari, I. Palmieri, M. Picascia, A. Pichiecchio, F. Esposito, M. Cirillo, F. Di Nardo, S. Aloisio, M. Siciliano, M. Fusar Poli, M. Stanziano, B. Garavaglia, F. Cazzaniga, C. Reale, I. Tramacere, S. Priori, P. Amami, S. Piacentini, MG. Bruzzone, M. Grisoli, F. Moda, R. Eleopra, A. Tessitore, EM. Valente, R. Cilia (Milan, Italy)

    Objective: To determine in Parkinson’s disease (PD) patients carrying GBA mutation the role of Ambroxol (ABX) on the progression of cognitive performance (primary aim), motor…
  • 2023 International Congress

    APOE-ɛ4 status and cognitive decline after subthalamic nucleus-deep brain stimulation in Parkinson’s disease: preliminary results of the GENEPARK-DBS study

    A. Sánchez-Soblechero, G. Lafuente, S. Pérez, G. Velilla, M. González-Sánchez, E. González-Turiño, J. Suárez, F. Grandas, V. álvarez, B. Dela Casa (Madrid, Spain)

    Objective: The aim of this study was to evaluate wheter the presence of APOE-ε4 in a cohort of Parkinson’s disease (PD) patients treated with subthalamic…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley